• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

十二指肠尼曼-匹克 C1 样蛋白 1 的表达与非酒精性脂肪性肝病中肝 X 受体的表达呈负相关。

Duodenal Niemann-Pick C1-like 1 expression was negatively correlated with liver X receptor expression in nonalcoholic fatty liver disease.

机构信息

Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea.

Department of Internal Medicine, Hanyang University School of Medicine, Seoul, Korea.

出版信息

Korean J Intern Med. 2019 Jul;34(4):777-784. doi: 10.3904/kjim.2017.100. Epub 2018 Feb 23.

DOI:10.3904/kjim.2017.100
PMID:29466845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6610185/
Abstract

BACKGROUND/AIMS: Intestinal cholesterol absorption includes intestinal Niemann-Pick C1-like 1 (NPC1L1) and is an important target pathway in nonalcoholic fatty liver disease (NAFLD). We investigated the expression of NPC1L1 and its correlation with liver X receptor (LXR) expression in peripheral mononuclear (PMN) cells in patients with NAFLD.

METHODS

We evaluated intestinal expression of NPC1L1 in 25 NAFLD patients and 28 healthy controls. We calculated the mRNA expression levels of LXR and farnesoid X receptor (FXR), which are master players of cholesterol metabolism in PMN cells. The protein expression of ABCA1, ABCG5/8, NPC1L1, SREBP, LXR, FXR, and CD36 was measured on tissue samples from the duodenum and ileum.

RESULTS

The expression of LXR (p = 0.01) and FXR (p = 0.03) in PMN cells was increased in the NAFLD group compared to the control group. Duodenal NPC1L1 decreased in the NAFLD group compared to the healthy controls (3.38 ± 1.4 vs. 2.42 ± 1.2, p = 0.05). NPC1L1 expression in the duodenum was negatively correlated with LXR expression in PMN cells. Expression of LXR and FXR in the ileum was also negatively correlated with the expression of LXR in PMN cells.

CONCLUSION

Duodenal NPC1L1 expression was decreased in NAFLD and was negatively correlated with LXR expression in PMN cells.

摘要

背景/目的:肠道胆固醇吸收包括肠道 Niemann-Pick C1 样 1(NPC1L1),是非酒精性脂肪性肝病(NAFLD)的重要靶点途径。我们研究了 NPC1L1 在 NAFLD 患者外周血单核细胞(PMN)中的表达及其与肝 X 受体(LXR)表达的相关性。

方法

我们评估了 25 例 NAFLD 患者和 28 例健康对照者的肠道 NPC1L1 表达。我们计算了胆固醇代谢的主调控因子 LXR 和法尼醇 X 受体(FXR)在 PMN 细胞中的 mRNA 表达水平。在十二指肠和回肠组织样本上测量了 ABCA1、ABCG5/8、NPC1L1、SREBP、LXR、FXR 和 CD36 的蛋白表达。

结果

与对照组相比,NAFLD 组 PMN 细胞中 LXR(p = 0.01)和 FXR(p = 0.03)的表达增加。与健康对照组相比,NAFLD 组十二指肠 NPC1L1 表达降低(3.38 ± 1.4 对 2.42 ± 1.2,p = 0.05)。十二指肠 NPC1L1 表达与 PMN 细胞中 LXR 表达呈负相关。回肠中 LXR 和 FXR 的表达也与 PMN 细胞中 LXR 的表达呈负相关。

结论

NAFLD 患者十二指肠 NPC1L1 表达降低,与 PMN 细胞中 LXR 表达呈负相关。

相似文献

1
Duodenal Niemann-Pick C1-like 1 expression was negatively correlated with liver X receptor expression in nonalcoholic fatty liver disease.十二指肠尼曼-匹克 C1 样蛋白 1 的表达与非酒精性脂肪性肝病中肝 X 受体的表达呈负相关。
Korean J Intern Med. 2019 Jul;34(4):777-784. doi: 10.3904/kjim.2017.100. Epub 2018 Feb 23.
2
Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine.在肠道中,尼曼-匹克C1样1基因的表达受到肝脏X受体激活剂的下调。
Biochem Biophys Res Commun. 2006 Feb 24;340(4):1259-63. doi: 10.1016/j.bbrc.2005.12.137. Epub 2006 Jan 5.
3
Expression of liver X receptor correlates with intrahepatic inflammation and fibrosis in patients with nonalcoholic fatty liver disease.肝脏X受体的表达与非酒精性脂肪性肝病患者的肝内炎症和纤维化相关。
Dig Dis Sci. 2014 Dec;59(12):2975-82. doi: 10.1007/s10620-014-3289-x. Epub 2014 Aug 8.
4
Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing expression.肠道 CREBH 过表达通过降低表达来预防高胆固醇饮食诱导的高胆固醇血症。
Mol Metab. 2016 Sep 17;5(11):1092-1102. doi: 10.1016/j.molmet.2016.09.004. eCollection 2016 Nov.
5
Pravastatin Modulate Niemann-Pick C1-Like 1 and ATP-Binding Cassette G5 and G8 to Influence Intestinal Cholesterol Absorption.普伐他汀调节尼曼-匹克C1样蛋白1以及ATP结合盒转运体G5和G8以影响肠道胆固醇吸收。
J Pharm Pharm Sci. 2015;18(5):765-72. doi: 10.18433/j3m029.
6
Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner.阿坎酸通过 FXR/LXRs 依赖性途径调节非酒精性脂肪性肝病中的脂肪生成。
Chem Biol Interact. 2019 Sep 25;311:108794. doi: 10.1016/j.cbi.2019.108794. Epub 2019 Aug 14.
7
Hepatic Niemann-Pick C1-Like 1 exacerbates non-alcoholic fatty liver disease by re-absorbing specific biliary oxysterols.肝尼曼-皮克 C1 样 1 通过重吸收特定胆汁氧化固醇加剧非酒精性脂肪性肝病。
Biomed Pharmacother. 2022 Dec;156:113877. doi: 10.1016/j.biopha.2022.113877. Epub 2022 Oct 19.
8
Niemann-Pick C1-like 1 is required for an LXR agonist to raise plasma HDL cholesterol in mice.尼曼-匹克C1样蛋白1是肝脏X受体激动剂提高小鼠血浆高密度脂蛋白胆固醇所必需的。
Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):448-54. doi: 10.1161/ATVBAHA.107.160465. Epub 2008 Jan 10.
9
Nuclear receptors and nonalcoholic fatty liver disease.核受体与非酒精性脂肪性肝病
Biochim Biophys Acta. 2016 Sep;1859(9):1083-1099. doi: 10.1016/j.bbagrm.2016.03.002. Epub 2016 Mar 4.
10
The nuclear receptor FXR, but not LXR, up-regulates bile acid transporter expression in non-alcoholic fatty liver disease.核受体FXR而非LXR可上调非酒精性脂肪性肝病中胆汁酸转运蛋白的表达。
Ann Hepatol. 2015 Jul-Aug;14(4):487-93.

引用本文的文献

1
Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions.揭示代谢相关脂肪性肝病中的胆固醇代谢:分子靶点与天然产物干预
Pharmaceuticals (Basel). 2024 Aug 15;17(8):1073. doi: 10.3390/ph17081073.
2
Characterization of differentially expressed and lipid metabolism-related lncRNA-mRNA interaction networks during the growth of liver tissue through rabbit models.通过兔模型对肝组织生长过程中差异表达及脂质代谢相关lncRNA-mRNA相互作用网络的表征。
Front Vet Sci. 2022 Sep 1;9:998796. doi: 10.3389/fvets.2022.998796. eCollection 2022.
3
Farnesoid X Receptor Deficiency Induces Hepatic Lipid and Glucose Metabolism Disorder via Regulation of Pyruvate Dehydrogenase Kinase 4.

本文引用的文献

1
Nuclear receptors and cholesterol metabolism in the intestine.肠道中的核受体与胆固醇代谢
Atheroscler Suppl. 2015 Feb;17:9-11. doi: 10.1016/S1567-5688(15)50003-2.
2
Expression of liver X receptor correlates with intrahepatic inflammation and fibrosis in patients with nonalcoholic fatty liver disease.肝脏X受体的表达与非酒精性脂肪性肝病患者的肝内炎症和纤维化相关。
Dig Dis Sci. 2014 Dec;59(12):2975-82. doi: 10.1007/s10620-014-3289-x. Epub 2014 Aug 8.
3
KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.
法尼酯X受体缺乏通过调控丙酮酸脱氢酶激酶4诱导肝脏脂质和葡萄糖代谢紊乱。
Oxid Med Cell Longev. 2022 Feb 24;2022:3589525. doi: 10.1155/2022/3589525. eCollection 2022.
4
Role of Cholesterol-Associated Steatohepatitis in the Development of NASH.胆固醇相关性脂肪性肝炎在 NASH 发展中的作用。
Hepatol Commun. 2022 Jan;6(1):12-35. doi: 10.1002/hep4.1801. Epub 2021 Aug 24.
KASL临床实践指南:非酒精性脂肪性肝病的管理
Clin Mol Hepatol. 2013 Dec;19(4):325-48. doi: 10.3350/cmh.2013.19.4.325. Epub 2013 Dec 28.
4
Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis.非酒精性脂肪性肝病:肝脂肪变性的分子机制。
Clin Mol Hepatol. 2013 Sep;19(3):210-5. doi: 10.3350/cmh.2013.19.3.210. Epub 2013 Sep 30.
5
Atherosclerosis: lessons from LXR and the intestine.动脉粥样硬化:从 LXR 和肠道中得到的启示。
Trends Endocrinol Metab. 2013 Mar;24(3):120-8. doi: 10.1016/j.tem.2012.10.004. Epub 2012 Nov 15.
6
Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR.核甾醇激活受体 LXR 和 FXR 对代谢的转录整合。
Nat Rev Mol Cell Biol. 2012 Mar 14;13(4):213-24. doi: 10.1038/nrm3312.
7
Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity.非酒精性脂肪肝疾病患者的胆固醇合成增加,吸收减少,且与肥胖无关。
J Hepatol. 2011 Jan;54(1):153-9. doi: 10.1016/j.jhep.2010.05.037. Epub 2010 Aug 22.
8
Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis.肠特异性 LXR 激活可刺激胆固醇逆转运并预防动脉粥样硬化。
Cell Metab. 2010 Aug 4;12(2):187-93. doi: 10.1016/j.cmet.2010.07.002.
9
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease.长期依折麦布治疗非酒精性脂肪性肝病患者的疗效。
J Gastroenterol. 2011 Jan;46(1):101-7. doi: 10.1007/s00535-010-0291-8. Epub 2010 Jul 24.
10
Fatty acid- and cholesterol transporter protein expression along the human intestinal tract.脂肪酸和胆固醇转运蛋白在人肠道中的表达。
PLoS One. 2010 Apr 29;5(4):e10380. doi: 10.1371/journal.pone.0010380.